Review



alexa 405 α mouse  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems alexa 405 α mouse
    Alexa 405 α Mouse, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/alexa 405 α mouse/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    alexa 405 α mouse - by Bioz Stars, 2026-05
    93/100 stars

    Images



    Similar Products

    93
    R&D Systems alexa 405 α mouse
    Alexa 405 α Mouse, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/alexa 405 α mouse/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    alexa 405 α mouse - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    90
    Thermo Fisher goat α-mouse igg alexa fluor™ 405

    Goat α Mouse Igg Alexa Fluor™ 405, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/goat α-mouse igg alexa fluor™ 405/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    goat α-mouse igg alexa fluor™ 405 - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher goat α-mouse alexa fluor 405

    Goat α Mouse Alexa Fluor 405, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/goat α-mouse alexa fluor 405/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    goat α-mouse alexa fluor 405 - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    94
    R&D Systems mouse monoclonal anti α sma a405

    Mouse Monoclonal Anti α Sma A405, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse monoclonal anti α sma a405/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    mouse monoclonal anti α sma a405 - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    90
    Millipore alexa fluor 405–conjugated mouse 6-11-b1 anti–ac-α-tubulin
    Miro1 K105Q is an axonal substrate for HDAC6 after exposure to CNS growth inhibitors. (A) End-point FRAP for Mito-GFP recovery in distal axons of DRGs transfected with WT, acetyl-mimetic (K40Q), or nonacetylatable <t>(K40A)</t> <t>α-tubulin</t> constructs and plated onto laminin is shown as average of normalized percentage recovery ± SEM at 960 s after bleach. Exposure to 10 µM TubA significantly increases Mito-GFP recovery in all three conditions (*, P ≤ 0.05 for TubA-treated vs. its corresponding DMSO control by two-way ANOVA with Tukey post hoc). Fig. S6 (A and B) shows that these <t>mutant</t> <t>α-tubulin</t> proteins are incorporated into axonal microtubules and expressed at relatively equivalent levels. (B) Representative immunoblot is shown for Miro1 from input and immunoprecipitations with magnetic bead-conjugated nonimmune IgGs or anti–Ac-Lys antibody cocktail from DRG neurons treated with 10 µM TubA for 4 h. 10% of the protein lysate was used as input (pull-down efficiency of 10.1 ± 1.9% for control vs. 14.1 ± 2.2% for TubA over n = 4; P = 0.012 by two-tailed Student’s t test). (C) HDAC6 is detected in Miro1 immunoprecipitates, and Miro1 is detected in HDAC6 immunoprecipitates from cultured DRG neurons by immunoblotting. 10% of the protein lysate was used as input. (D) Schematic of rat Miro1 sequence with residues previously reported to be acetylated in nonneuronal cells indicated (K105, K525, and K629 plus (Ac)). The glutamate-to-lysine mutations that were previously reported to decrease Miro1 Ca 2+ sensitivity are indicated by (KK). Residues corresponding to GTPase, EF-hand, and transmembrane (TM) domains are shown. (E) Representative immunoblots are shown for anti-Myc from DRG neurons transfected with Myc-Miro1 K105A , Myc-Miro1 K525A , or Myc-Miro1 K629A plasmids and treated with 10 µM TubA for 4 h at 36 h after transfection (40 h in vitro). Input (10%) and immunoprecipitations with nonimmune IgG and Ac-Lys antibody cocktail. (F) Representative immunoblots are shown for anti–Miro1-AcK105 for DRG lysates ± 10 µM TubA. For the righthand blot, the anti–Miro1-AcK105 antibody was preincubated with 100 µg/ml immunizing peptide (short exposure = 30 s; long exposure = 3 min). (G and H) Representative immunoblots are shown in G for anti–Miro1-AcK105, anti-Miro1, and anti-Erk1 (loading control) from lysates of DRG cultures treated with 10 µg/ml aggrecan (CSPG) or 1 µM thapsigargin (Thapsi) for 4 h. H shows quantification of immunoblot signals across multiple experiments as average fold-change relative to control ± SEM ( n = 3; *, P ≤ 0.05 by one-way ANOVA with pairwise comparison and Tukey post hoc tests). (I and J) Representative confocal projection images (XYZ) for anti-Miro1-AcK105 (Cy5), anti-NF (Cy3), and MitoTracker Green are shown as indicated in J for control, aggrecan-treated (CSPG) or thapsigargin-treated cultures. ImageJ was used for pseudocoloring and channel merging. Panel I shows quantification of the axonal anti-Miro1-AcK105 signals under these conditions as average fold-change relative to control ± SEM ( n = 20; *, P ≤ 0.05 by one-way ANOVA with pairwise comparison and Tukey post hoc; scale bar = 20 µm; 100×/1.4 NA objective used).
    Alexa Fluor 405–Conjugated Mouse 6 11 B1 Anti–Ac α Tubulin, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/alexa fluor 405–conjugated mouse 6-11-b1 anti–ac-α-tubulin/product/Millipore
    Average 90 stars, based on 1 article reviews
    alexa fluor 405–conjugated mouse 6-11-b1 anti–ac-α-tubulin - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    Image Search Results


    Journal: Cell Reports Methods

    Article Title: Modular dual-color BiAD sensors for locus-specific readout of epigenome modifications in single cells

    doi: 10.1016/j.crmeth.2024.100739

    Figure Lengend Snippet:

    Article Snippet: goat α-mouse IgG Alexa Fluor™ 405 , Invitrogen , A-31553.

    Techniques: Virus, Recombinant, Software

    Miro1 K105Q is an axonal substrate for HDAC6 after exposure to CNS growth inhibitors. (A) End-point FRAP for Mito-GFP recovery in distal axons of DRGs transfected with WT, acetyl-mimetic (K40Q), or nonacetylatable (K40A) α-tubulin constructs and plated onto laminin is shown as average of normalized percentage recovery ± SEM at 960 s after bleach. Exposure to 10 µM TubA significantly increases Mito-GFP recovery in all three conditions (*, P ≤ 0.05 for TubA-treated vs. its corresponding DMSO control by two-way ANOVA with Tukey post hoc). Fig. S6 (A and B) shows that these mutant α-tubulin proteins are incorporated into axonal microtubules and expressed at relatively equivalent levels. (B) Representative immunoblot is shown for Miro1 from input and immunoprecipitations with magnetic bead-conjugated nonimmune IgGs or anti–Ac-Lys antibody cocktail from DRG neurons treated with 10 µM TubA for 4 h. 10% of the protein lysate was used as input (pull-down efficiency of 10.1 ± 1.9% for control vs. 14.1 ± 2.2% for TubA over n = 4; P = 0.012 by two-tailed Student’s t test). (C) HDAC6 is detected in Miro1 immunoprecipitates, and Miro1 is detected in HDAC6 immunoprecipitates from cultured DRG neurons by immunoblotting. 10% of the protein lysate was used as input. (D) Schematic of rat Miro1 sequence with residues previously reported to be acetylated in nonneuronal cells indicated (K105, K525, and K629 plus (Ac)). The glutamate-to-lysine mutations that were previously reported to decrease Miro1 Ca 2+ sensitivity are indicated by (KK). Residues corresponding to GTPase, EF-hand, and transmembrane (TM) domains are shown. (E) Representative immunoblots are shown for anti-Myc from DRG neurons transfected with Myc-Miro1 K105A , Myc-Miro1 K525A , or Myc-Miro1 K629A plasmids and treated with 10 µM TubA for 4 h at 36 h after transfection (40 h in vitro). Input (10%) and immunoprecipitations with nonimmune IgG and Ac-Lys antibody cocktail. (F) Representative immunoblots are shown for anti–Miro1-AcK105 for DRG lysates ± 10 µM TubA. For the righthand blot, the anti–Miro1-AcK105 antibody was preincubated with 100 µg/ml immunizing peptide (short exposure = 30 s; long exposure = 3 min). (G and H) Representative immunoblots are shown in G for anti–Miro1-AcK105, anti-Miro1, and anti-Erk1 (loading control) from lysates of DRG cultures treated with 10 µg/ml aggrecan (CSPG) or 1 µM thapsigargin (Thapsi) for 4 h. H shows quantification of immunoblot signals across multiple experiments as average fold-change relative to control ± SEM ( n = 3; *, P ≤ 0.05 by one-way ANOVA with pairwise comparison and Tukey post hoc tests). (I and J) Representative confocal projection images (XYZ) for anti-Miro1-AcK105 (Cy5), anti-NF (Cy3), and MitoTracker Green are shown as indicated in J for control, aggrecan-treated (CSPG) or thapsigargin-treated cultures. ImageJ was used for pseudocoloring and channel merging. Panel I shows quantification of the axonal anti-Miro1-AcK105 signals under these conditions as average fold-change relative to control ± SEM ( n = 20; *, P ≤ 0.05 by one-way ANOVA with pairwise comparison and Tukey post hoc; scale bar = 20 µm; 100×/1.4 NA objective used).

    Journal: The Journal of Cell Biology

    Article Title: Deacetylation of Miro1 by HDAC6 blocks mitochondrial transport and mediates axon growth inhibition

    doi: 10.1083/jcb.201702187

    Figure Lengend Snippet: Miro1 K105Q is an axonal substrate for HDAC6 after exposure to CNS growth inhibitors. (A) End-point FRAP for Mito-GFP recovery in distal axons of DRGs transfected with WT, acetyl-mimetic (K40Q), or nonacetylatable (K40A) α-tubulin constructs and plated onto laminin is shown as average of normalized percentage recovery ± SEM at 960 s after bleach. Exposure to 10 µM TubA significantly increases Mito-GFP recovery in all three conditions (*, P ≤ 0.05 for TubA-treated vs. its corresponding DMSO control by two-way ANOVA with Tukey post hoc). Fig. S6 (A and B) shows that these mutant α-tubulin proteins are incorporated into axonal microtubules and expressed at relatively equivalent levels. (B) Representative immunoblot is shown for Miro1 from input and immunoprecipitations with magnetic bead-conjugated nonimmune IgGs or anti–Ac-Lys antibody cocktail from DRG neurons treated with 10 µM TubA for 4 h. 10% of the protein lysate was used as input (pull-down efficiency of 10.1 ± 1.9% for control vs. 14.1 ± 2.2% for TubA over n = 4; P = 0.012 by two-tailed Student’s t test). (C) HDAC6 is detected in Miro1 immunoprecipitates, and Miro1 is detected in HDAC6 immunoprecipitates from cultured DRG neurons by immunoblotting. 10% of the protein lysate was used as input. (D) Schematic of rat Miro1 sequence with residues previously reported to be acetylated in nonneuronal cells indicated (K105, K525, and K629 plus (Ac)). The glutamate-to-lysine mutations that were previously reported to decrease Miro1 Ca 2+ sensitivity are indicated by (KK). Residues corresponding to GTPase, EF-hand, and transmembrane (TM) domains are shown. (E) Representative immunoblots are shown for anti-Myc from DRG neurons transfected with Myc-Miro1 K105A , Myc-Miro1 K525A , or Myc-Miro1 K629A plasmids and treated with 10 µM TubA for 4 h at 36 h after transfection (40 h in vitro). Input (10%) and immunoprecipitations with nonimmune IgG and Ac-Lys antibody cocktail. (F) Representative immunoblots are shown for anti–Miro1-AcK105 for DRG lysates ± 10 µM TubA. For the righthand blot, the anti–Miro1-AcK105 antibody was preincubated with 100 µg/ml immunizing peptide (short exposure = 30 s; long exposure = 3 min). (G and H) Representative immunoblots are shown in G for anti–Miro1-AcK105, anti-Miro1, and anti-Erk1 (loading control) from lysates of DRG cultures treated with 10 µg/ml aggrecan (CSPG) or 1 µM thapsigargin (Thapsi) for 4 h. H shows quantification of immunoblot signals across multiple experiments as average fold-change relative to control ± SEM ( n = 3; *, P ≤ 0.05 by one-way ANOVA with pairwise comparison and Tukey post hoc tests). (I and J) Representative confocal projection images (XYZ) for anti-Miro1-AcK105 (Cy5), anti-NF (Cy3), and MitoTracker Green are shown as indicated in J for control, aggrecan-treated (CSPG) or thapsigargin-treated cultures. ImageJ was used for pseudocoloring and channel merging. Panel I shows quantification of the axonal anti-Miro1-AcK105 signals under these conditions as average fold-change relative to control ± SEM ( n = 20; *, P ≤ 0.05 by one-way ANOVA with pairwise comparison and Tukey post hoc; scale bar = 20 µm; 100×/1.4 NA objective used).

    Article Snippet: Cells were washed three times in PBST and then incubated with Cy5-conjugated anti-mouse IgG (1:200; Jackson Immunoresearch) in 1% blocking buffer for 1 h. Cells were washed twice with PBST and then incubated with the Alexa Fluor 405–conjugated mouse 6-11-B1 anti–Ac-α-tubulin (1:50; Sigma-Aldrich; T6793) and FITC-conjugated Tub 2.1 mouse anti–β-tubulin IgG (1:50; Sigma-Aldrich; T4026) in 1% blocking buffer for 1.5 h. Coverslips were washed twice with PBS then stained with Actin-Red 555 Ready Probe for 30 min (1:25 dilution of 200 U/ml stock; Thermo Fisher Scientific; R37112).

    Techniques: Transfection, Construct, Mutagenesis, Western Blot, Two Tailed Test, Cell Culture, Sequencing, In Vitro